{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:34:19Z","timestamp":1740105259275,"version":"3.37.3"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jpeds.2018.08.062","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T01:33:40Z","timestamp":1538098420000},"page":"11-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best Treatment"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8855-9746","authenticated-orcid":false,"given":"Sarah H.","family":"O'Brien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny M.","family":"Despotovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy E.","family":"Neunert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2018.08.062_bib0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jpeds.2018.07.065","article-title":"Efficacy and safety of anti-D immunoglobulins versus intravenous immunoglobulins for immune thrombocytopenia in children: systematic review and meta-analysis of randomized controlled trials","volume":"204","author":"Lioger","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2018.08.062_bib0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/jth.12813","article-title":"Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review","volume":"13","author":"Neunert","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpeds.2018.08.062_bib0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1160\/TH17-06-0387","article-title":"Platelet function in ITP, independent of platelet count, is consistent over time and is associated with both current and subsequent bleeding severity","volume":"118","author":"Frelinger","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpeds.2018.08.062_bib0025","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1067\/mpd.2002.128547","article-title":"Grading of hemorrhage in children with idiopathic thrombocytopenic purpura","volume":"141","author":"Buchanan","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2018.08.062_bib0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1185\/03007995.2011.644849","article-title":"Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia","volume":"28","author":"Fogarty","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpeds.2018.08.062_bib0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.2007.06635.x","article-title":"The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP","volume":"138","author":"Page","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jpeds.2018.08.062_bib0040","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jpeds.2005.11.019","article-title":"Single dose of anti-D immune globulin at 75 microg\/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children","volume":"148","author":"Tarantino","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2018.08.062_bib0045","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1046\/j.1365-2141.2001.02627.x","article-title":"A dose of 75 microg\/kg\/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg\/kg\/d in adults with immune thrombocytopenic purpura","volume":"112","author":"Newman","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jpeds.2018.08.062_bib0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/pbc.20830","article-title":"A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP)","volume":"48","author":"O'Brien","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2018.08.062_bib0055","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jpeds.2018.08.062_bib9000","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0022-3476(05)80400-7","article-title":"A prospective randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenia purpura","volume":"123","author":"Blanchette","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2018.08.062_bib9005","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1182\/blood-2018-02-830844","article-title":"Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial","volume":"132","author":"Heitink-Polle","year":"2018","journal-title":"Blood"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347618312368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347618312368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T04:52:35Z","timestamp":1545195155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347618312368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":12,"alternative-id":["S0022347618312368"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2018.08.062","relation":{},"ISSN":["0022-3476"],"issn-type":[{"type":"print","value":"0022-3476"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best Treatment","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2018.08.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2018.07.065","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}